World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
20951
World Ranking
19383
National Ranking
781

V. De Stefano publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where V. De Stefano sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 406 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

V. De Stefano D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where V. De Stefano sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 74 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

V. De Stefano is affiliated with the Catholic University of the Sacred Heart in Italy. Their research is primarily situated within the field of Medicine, with a strong focus on Hematology, Genetics, Molecular Biology, Oncology, and Rheumatology. The scientist has contributed extensively to understanding various hematologic disorders and treatments.

The main topics of their work encompass:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Eosinophilic Disorders and Syndromes
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Protein Degradation and Inhibitors
  • Kruppel-like factors research

De Stefano's research outputs include numerous publications across prominent journals. Frequent publication venues for their work are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Leukemia
  • Blood Cancer Journal
  • American Journal of Hematology

Collaborations have been notable with multiple co-authors, including:

  • Alessandro M. Vannucchi
  • Elena Rossi
  • Tiziano Barbui
  • Francesca Palandri
  • Paola Guglielmelli

Selected recent papers authored or co-authored by De Stefano illustrate their engagement with clinical trials and real-life studies related to hematologic diseases:

  • Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial (2020) - The Lancet Haematology
  • LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma (2022) - Leukemia
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study (2023) - The Lancet
  • Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial (2021) - The Lancet Haematology
  • Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients (2020) - British Journal of Haematology

Best Publications

  • Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

    Roberto Marchioli;Guido Finazzi;Giorgina Specchia;Rossella Cacciola

  • Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

    V De Stefano;G Finazzi;PM Mannucci

  • The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation

    V De Stefano;I Martinelli;P M Mannucci;K Paciaroni

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.

    Alessandro M. Vannucchi;Elisabetta Antonioli;Paola Guglielmelli;Alessandro Rambaldi

  • Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including 2310 cases and 3204 controls

    Joseph Emmerich;Frits R. Rosendaal;Marco Cattaneo;Maurizio Margaglione

  • Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

    Michele Cavo;Lucia Pantani;Maria Teresa Petrucci;Francesca Patriarca

  • Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

    Valerio De Stefano;Tommaso Za;Elena Rossi;Alessandro M. Vannucchi

  • Prothrombin G20210A Mutant Genotype Is a Risk Factor for Cerebrovascular Ischemic Disease in Young Patients

    Valerio De Stefano;Patrizia Chiusolo;Katia Paciaroni;Ida Casorelli

  • Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia

    Francesco Zaja;Michele Baccarani;Patrizio Mazza;Monica Bocchia

  • A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    F Passamonti;T Giorgino;B Mora;P Guglielmelli

  • The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment.

    V. De Stefano;F. Sorà;E. Rossi;P. Chiusolo

  • Epidemiology of factor V Leiden: clinical implications.

    V De Stefano;P Chiusolo;K Paciaroni;G Leone

  • Screening for inherited thrombophilia: indications and therapeutic implications

    V De Stefano;E Rossi;K Paciaroni;G Leone

  • Inherited Thrombophilia and First Venous Thromboembolism during Pregnancy and Puerperium

    Ida Martinelli;Valerio De Stefano;Emanuela Taioli;Katia Paciaroni

  • Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders.

    V. De Stefano;A. Fiorini;E. Rossi;T. Za

  • Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia.

    T Barbui;A M Vannucchi;V Buxhofer-Ausch;V De Stefano

  • Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial.

    Maria-Victoria Mateos;Hareth Nahi;Wojciech Legiec;Sebastian Grosicki

  • Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry

    Walter Ageno;Nicoletta Riva;Sam Schulman;Jan Beyer-Westendorf

  • Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S

    V De Stefano;G Leone;S Mastrangelo;A Tripodi

Frequent Co-Authors

Giuseppe Leone
Giuseppe Leone Catholic University of the Sacred Heart
Livio Pagano
Livio Pagano Catholic University of the Sacred Heart
Sergio Rutella
Sergio Rutella Nottingham Trent University
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
David Lane
David Lane Imperial College London
Maurizio Margaglione
Maurizio Margaglione University of Foggia
Paola Guglielmelli
Paola Guglielmelli University of Florence
Walter Ageno
Walter Ageno University of Insubria
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Alessandro Rambaldi
Alessandro Rambaldi University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your medical or healthcare career beyond a traditional MD? Online degree programs are making it more accessible to earn advanced qualifications while balancing work and life commitments. An affordable mha online programs option can help you build the skills needed to move into healthcare management, overseeing hospitals, clinics, or health systems.

For nursing professionals, the best online bsn to dnp programs offer opportunities to reach a clinical doctorate level, paving the way for leadership and advanced practice roles.

Aspiring pharmacists can look into pharm d online programs to obtain their doctorate, a crucial credential for pharmacy careers across settings.

Additionally, a health information management degree online can equip you for the evolving intersection between healthcare and technology, opening doors to roles in data analysis, records management, and health IT.

Each pathway offers unique opportunities and flexibility, allowing you to tailor your career to your interests, time, and educational goals.

Best Scientists Citing V. De Stefano

Trending Scientists